FDA reviewing main goals of Pozen drug study – Forbes

Posted on by
FDA reviewing main goals of Pozen drug study
Forbes, NY - 15 hours ago
PN 400 is a combination of the pain reliever naproxen and the acid reflux drug Nexium, and is being developed with Nexium maker AstraZeneca PLC. …

Source:FDA reviewing main goals of Pozen drug study – Forbes

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>